Acurx Pharmaceuticals (ACXP) Short Interest Ratio & Short Volume

Short interest is the volume of Acurx Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of September 30th, investors have sold 491,700 shares of ACXP short. 3.55% of Acurx Pharmaceuticals' shares are currently sold short. Learn More on Acurx Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACXP shares currently have a short interest ratio of 8.0. Learn More on Acurx Pharmaceuticals's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Acurx Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.55% of Acurx Pharmaceuticals' floating shares are currently sold short.

Acurx Pharmaceuticals saw a increase in short interest in the month of September. As of September 30th, there was short interest totaling 491,700 shares, an increase of 2.8% from the previous total of 478,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Acurx Pharmaceuticals currently has issued a total of 16,250,000 shares. Some of Acurx Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acurx Pharmaceuticals currently has a public float of 13,840,000 shares.

3.55% of Acurx Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies compare to Acurx Pharmaceuticals: Galmed Pharmaceuticals Ltd. (2.30%), Aytu BioPharma, Inc. (4.41%), Portage Biotech Inc. (4.16%), PDS Biotechnology Co. (13.01%), Cardiff Oncology, Inc. (14.67%), Puma Biotechnology, Inc. (9.70%), Outlook Therapeutics, Inc. (19.37%), Century Therapeutics, Inc. (10.80%), Journey Medical Co. (0.87%), Sagimet Biosciences Inc. (9.32%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.04 billion), AppLovin Co. ($2.69 billion), Nu Holdings Ltd. ($2.64 billion), Paychex, Inc. ($2.61 billion), Cencora, Inc. ($2.30 billion), Aptiv PLC ($2.09 billion), Moderna, Inc. ($2.09 billion), Tractor Supply ($2.04 billion), Coinbase Global, Inc. ($1.97 billion), and International Paper ($1.95 billion). View all of the most shorted stocks.

Short selling ACXP is an investing strategy that aims to generate trading profit from Acurx Pharmaceuticals as its price is falling. ACXP shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Acurx Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ACXP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACXP, twice per month. The most recent reporting period available is September, 30 2024.